Quick Answer
PMV Pharmaceuticals, Inc. reported Net Income of -$77.74 million for fiscal year 2025.
PMV Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$77.74M | -32.4% |
| 2024 | -$58.71M | +14.9% |
| 2023 | -$68.96M | +5.9% |
| 2022 | -$73.32M | -26.7% |
| 2021 | -$57.85M | -68.0% |
| 2020 | -$34.44M | -35.8% |
| 2019 | -$25.35M | -44.6% |
| 2018 | -$17.54M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$21.06M | -9.5% | +0.7% |
| June 30, 2025 | -$21.21M | -1648.6% | -21.6% |
| March 31, 2025 | -$17.44M | -14.2% | +9.3% |
| September 30, 2024 | -$19.23M | -15.5% | -1485.0% |
| June 30, 2024 | -$1.21M | +93.0% | +92.1% |
| March 31, 2024 | -$15.27M | +20.2% | +8.2% |
| September 30, 2023 | -$16.64M | +8.7% | +4.6% |
| June 30, 2023 | -$17.44M | -0.7% | +8.8% |
- PMV Pharmaceuticals, Inc. showed a decrease of -32.4% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, PMV Pharmaceuticals, Inc.’s net income has declined by 343.3% (from -$17.54 million to -$77.74 million).
- The most recent figure is from PMV Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: